Navigation Links
Erg gene key to blood stem cell 'self-renewal'
Date:2/16/2011

Scientists from the Walter and Eliza Hall Institute have begun to unravel how blood stem cells regenerate themselves, identifying a key gene required for the process.

The discovery that the Erg gene is vitally important to blood stem cells' unique ability to self-renew could give scientists new opportunities to use blood stem cells for tissue repair, transplantation and other therapeutic applications.

Professor Doug Hilton, Dr Samir Taoudi and colleagues from the institute's Molecular Medicine and Cancer and Haematology divisions led the study. Dr Taoudi said the research aimed to understand how blood stem cells are made.

"One of the key features of blood stem cells, one that could be exploited for therapeutic use, is their ability to regenerate or renew themselves," Dr Taoudi said. "However, relatively little is known about how this occurs, or the molecular pathways that specifically control regeneration."

Blood stem cells are required to produce and maintain the blood system throughout an organism's lifetime. They are multipotent cells, meaning they are able to form any cell of the blood system (but not other cells), and they self-renew, so they are a source of endless supply. However, one major barrier to their therapeutic use is that the cells can only be isolated in numbers too low for practical use and efforts to expand the number of cells often causes them to turn into more mature cells.

"At the moment, if you take stem cells from a person and try to expand them, many of the stem cells lose their ability to regenerate," Dr Taoudi said. "The practical aim of our research is to find ways in which you could take stem cells collected from bone marrow or cord blood and 'switch on' expression of particular sets of genes, encouraging the stem cells to expand, essentially creating your own endless supply of blood stem cells."

Institute researchers had previously discovered that ERG was vital for the proper function of adult blood stem cells. They decided to look at blood stem cells in a developing embryo, a time when the cells are particularly active, to determine ERG's role in stem cell production and maintenance.

"We found that during development, ERG was not needed for the original blood stem cells to be made, or to produce mature blood cells," Dr Taoudi said. "But without ERG, these new blood stem cells rapidly decreased as they divided to produce more blood, so that they were almost completely exhausted by the time the mouse was born."

Further testing revealed that two other genes important in embryonic development, GATA2 and RUNX1, were controlled by ERG at the blood producing stage of development.

"These genes are called transcription factors, they are the 'switches' that turn on and off other genes," Dr Taoudi said. "Individually, these genes are not essential for regeneration, but if you lose both, the stem cells are quickly exhausted. This is a key part of the puzzle, but we will continue to work to find out how these genes directly control self-renewal, and the signals that actually tell the stem cell to regenerate."

Dr Taoudi said that although the finding had promise for the future therapeutic use of blood stem cells, there was still a lot of work to be done.

"We have found part of the pathway required for the expansion of blood stem cells under normal conditions, but from a translation perspective, we still need to establish whether increasing expression of these genes will actually lead to expansion in a culture dish," he said.


'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Related biology news :

1. Blood-clotting protein linked to cancer and septicemia
2. Conversion of brain tumor cells into blood vessels thwarts treatment efforts
3. Red blood cell hormone modulates the immune system
4. Common antibiotics and blood pressure medication may result in hospitalization
5. Blood pressure control system found in kidneys structural units
6. New method will triple amount of genetic information from newborn blood spot screenings
7. Biomedical breakthrough: Blood vessels for lab-grown tissues
8. Researchers investigate why a limited number of white blood cells are attracted to injured tissue
9. UTHealth studies cord blood stem cells for pediatric traumatic brain injury
10. High red blood cell folate levels linked to silenced tumor-suppressors
11. Cord blood cell transplantation provides improvement for severely brain-injured child
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Erg gene key to blood stem cell 'self-renewal'
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: